Brief: Gracell Biotechnologies Reports Fourth Quarter And Full Year 2021 Unaudited Financial Results
14/03/2022 11:42
March 14 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES REPORTS FOURTH QUARTER AND FULL
YEAR
2021 UNAUDITED FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* GRACELL BIOTECHNOLOGIES INC - WELL-FUNDED WITH CASH RUNWAY
INTO
2024
* GRACELL BIOTECHNOLOGIES INC - QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nGNX4NfCb3
Further company coverage: GRCL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27